Suppr超能文献

丝氨酸蛋白酶在将高分子量(600 kDa)形式的血管紧张素转换酶转化为低分子量形式(190 kDa)过程中的作用

[Participation of serine proteinases in transforming the high molecular weight (600 kDa) form of angiotensin 1-converting enzyme into the low molecular weight form (190 kDa)].

作者信息

Kugaevskaia E V, Pavlikhina L V, Eliseeva Iu E

出版信息

Vopr Med Khim. 1994 May-Jun;40(3):9-11.

PMID:8079446
Abstract

A high molecular form of angiotensin-converting enzyme with mol mass about 600 kDa was found simultaneously with the well-known low molecular enzyme form of 190 kDa after fractionation of freshly prepared extracts from bovine kidney cortex and lung tissues by means of ammonium sulfate or gel filtration on Sephadex G-200. The rate of substrate hydrolysis was adequately Cl'-dependent for both these enzyme forms and specific inhibitors nonapeptide SQ 20881 and pentapeptide SQ 20475 inhibited similarly their activity. The enzyme high molecular form transformed into its low molecular derivative after storage, in freezing-thawing and ultrafiltration. Aprotinin, the inhibitor of serine proteinases, inhibited this kind of transformation. Stable form of the high molecular angiotensin-converting enzyme, which did not transform into its low molecular derivative, was obtained after treatment with agarose-immobilized aprotinin. Endogenous serine proteinases, which may regulate the angiotensin-converting activity in vivo, appears to be responsible for the enzyme transformation into its low molecular derivative.

摘要

在用硫酸铵分级分离或通过Sephadex G - 200凝胶过滤对新鲜制备的牛肾皮质和肺组织提取物进行分级分离后,发现了一种分子量约为600 kDa的高分子形式的血管紧张素转换酶,同时还发现了众所周知的分子量为190 kDa的低分子酶形式。这两种酶形式的底物水解速率都充分依赖于Cl⁻,并且特异性抑制剂九肽SQ 20881和五肽SQ 20475对它们活性的抑制作用相似。高分子形式的酶在储存、冻融和超滤后会转化为其低分子衍生物。丝氨酸蛋白酶抑制剂抑肽酶抑制了这种转化。用琼脂糖固定的抑肽酶处理后,获得了不会转化为低分子衍生物的高分子血管紧张素转换酶的稳定形式。内源性丝氨酸蛋白酶可能在体内调节血管紧张素转换活性,似乎是该酶转化为低分子衍生物的原因。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验